Conformis Transformation Taking Longer Than Expected

Conformis reported 3Q22 orthopedic sales of $13.8 million, -3.3% compared to the third quarter of 2021. The company expects 2022 product revenue of around $58 million, achieving the low end of its guidance range but declining slightly compared to the previous year.

As the company transitions to a model focused on its Imprint knee system...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us